Search Results - "THRELKELD, Penny G"
-
1
In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268)
Published in The Journal of pharmacology and experimental therapeutics (01-12-2009)“…Some recently published in vitro studies with two metabotropic glutamate 2/3 receptor (mGluR(2/3)) agonists [(-)-2-oxa-4-aminobicyclo[3.1.0]…”
Get more information
Journal Article -
2
Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder
Published in Neuropsychopharmacology (New York, N.Y.) (01-11-2002)“…The selective norepinephrine (NE) transporter inhibitor atomoxetine (formerly called tomoxetine or LY139603) has been shown to alleviate symptoms in Attention…”
Get full text
Journal Article -
3
Comparative Affinity of Duloxetine and Venlafaxine for Serotonin and Norepinephrine Transporters in vitro and in vivo, Human Serotonin Receptor Subtypes, and Other Neuronal Receptors
Published in Neuropsychopharmacology (New York, N.Y.) (01-12-2001)“…The blockade of serotonin (5-HT) and norepinephrine (NE) transporters in vitro and in vivo by the dual 5-HT/NE reuptake inhibitors duloxetine and venlafaxine…”
Get full text
Journal Article -
4
R-fluoxetine Increases Extracellular DA, NE, As Well As 5-HT in Rat Prefrontal Cortex and Hypothalamus: An in vivo Microdialysis and Receptor Binding Study
Published in Neuropsychopharmacology (New York, N.Y.) (01-12-2002)“…The selective serotonin reuptake inhibitor fluoxetine consists of equal amounts of R and S stereoisomers. In this study, we investigated the pharmacologic…”
Get full text
Journal Article -
5
Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats
Published in Neuropharmacology (01-12-2003)“…Compounds that block both serotonin (5-HT) and norepinephrine (NE) transporters have been proposed to have improved antidepressant efficacy. We compared the…”
Get full text
Journal Article -
6
Novel Radiotracers for Imaging the Serotonin Transporter by Positron Emission Tomography: Synthesis, Radiosynthesis, and in Vitro and ex Vivo Evaluation of 11C-Labeled 2-(Phenylthio)araalkylamines
Published in Journal of medicinal chemistry (10-08-2000)“…A series of four 2-(phenylthio)araalkylamines have been radiolabeled with 11C and evaluated as potential radiotracers for imaging the serotonin transporter…”
Get full text
Journal Article -
7
Advances toward new antidepressants beyond SSRIS: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4
Published in Bioorganic & medicinal chemistry letters (17-05-2004)“…A series of 1-(1H-indol-4-yloxy)-3-(4-arylpiperidinyl)propan-2-ols possessing potent dual 5-HT(1A) receptor antagonism and serotonin reuptake inhibition was…”
Get full text
Journal Article -
8
Advances toward new antidepressants beyond SSRIs : 1-Aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 5
Published in Bioorganic & medicinal chemistry letters (01-05-2006)“…A series of 1-aryloxy-3-piperidinylpropan-2-ols possessing potent dual 5-HT1A receptor antagonism and serotonin reuptake inhibition was discovered…”
Get full text
Journal Article -
9
Advances toward new antidepressants beyond SSRIs: 1-Aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1
Published in Bioorganic & medicinal chemistry letters (02-06-2003)“…A series of 1-aryloxy-3-piperidinylpropan-2-ols possessing potent dual 5-HT(1A) receptor antagonism and serotonin reuptake inhibition was discovered…”
Get full text
Journal Article -
10
Advances toward new antidepressants beyond SSRIS: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 3
Published in Bioorganic & medicinal chemistry letters (17-11-2003)“…A series of 1-aryloxy-3-piperidinylpropan-2-ols possessing potent dual 5-HT(1A) receptor antagonism and serotonin reuptake inhibition was discovered…”
Get full text
Journal Article -
11
-
12
Expedited discovery of second generation NK-1 antagonists: identification of a nonbasic aryloxy substituent
Published in Bioorganic & medicinal chemistry letters (09-07-2001)“…Solution-phase, parallel-synthesis techniques were used to optimize a series of nonbasic NK-1 antagonists, resulting in the identification of ( R)- 26, an…”
Get full text
Journal Article -
13
3-Aryl-1,2-diacetamidopropane Derivatives as Novel and Potent NK-1 Receptor Antagonists
Published in Journal of medicinal chemistry (02-02-1996)“…Early structure−activity studies on racemic tryptophan ester and amide NK-1 antagonists 5−7 led to the discovery that the potency of the series could be…”
Get full text
Journal Article -
14
Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors
Published in Biochemical pharmacology (01-04-1983)“…Fluoxetine and nine other antidepressant drugs which interact with brain receptors for neurotransmitters were studied in vitro using radioligand-binding…”
Get more information
Journal Article -
15
Advances toward new antidepressants beyond SSRIs: 1-Aryloxy-3-piperidinylpropan-2-ols with dual 5-HT 1A receptor antagonism/SSRI activities. Part 5
Published in Bioorganic & medicinal chemistry letters (2006)“…A series of 1-aryloxy-3-piperidinylpropan-2-ols possessing potent dual 5-HT 1A receptor antagonism and serotonin reuptake inhibition was discovered. 1-(1…”
Get full text
Journal Article -
16
Advances toward new antidepressants beyond SSRIs: 1-Aryloxy-3-piperidinylpropan-2-ols with dual 5-HT sub(1A) receptor antagonism/SSRI activities
Published in Bioorganic & medicinal chemistry letters (01-01-2006)“…A series of 1-aryloxy-3-piperidinylpropan-2-ols possessing potent dual 5- HT sub(1A) receptor antagonism and serotonin reuptake inhibition was discovered…”
Get full text
Journal Article -
17
-
18
-
19
-
20
Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT 1A receptor antagonism/SSRI activities. Part 4
Published in Bioorganic & medicinal chemistry letters (2004)“…A series of 1-(1 H-indol-4-yloxy)-3-(4-arylpiperidinyl)propan-2-ols possessing potent dual 5-HT 1A receptor antagonism and serotonin reuptake inhibition was…”
Get full text
Journal Article